O
ZBH icon

OppenheimerFunds’s Zimmer Biomet ZBH Stock Holding History

OppenheimerFunds’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$403M Buy
3,251,023
+238,246
+8% +$27.1M 0.5% 47
2018
Q4 		$303M Buy
3,012,777
+460,575
+18% +$51.8M 0.43% 57
2018
Q3 		$326M Buy
2,552,202
+540,651
+27% +$64.3M 0.38% 64
2018
Q2 		$218M Sell
2,011,551
-126,411
-6% -$13.8M 0.26% 104
2018
Q1 		$226M Sell
2,137,962
-585,972
-22% -$68M 0.28% 94
2017
Q4 		$319M Buy
2,723,934
+351,070
+15% +$39.7M 0.39% 59
2017
Q3 		$270M Sell
2,372,864
-133,908
-5% -$15.5M 0.33% 77
2017
Q2 		$312M Sell
2,506,772
-11,585
-0.5% -$1.37M 0.39% 68
2017
Q1 		$299M Sell
2,518,357
-356,795
-12% -$40.4M 0.36% 73
2016
Q4 		$288M Buy
2,875,152
+33,524
+1% +$3.59M 0.36% 74
2016
Q3 		$359M Buy
2,841,628
+156,407
+6% +$19.3M 0.45% 49
2016
Q2 		$314M Buy
2,685,221
+197,162
+8% +$22.3M 0.41% 64
2016
Q1 		$258M Buy
2,488,059
+356,555
+17% +$34.5M 0.34% 73
2015
Q4 		$212M Buy
2,131,504
+14,035
+0.7% +$1.37M 0.27% 99
2015
Q3 		$193M Sell
2,117,469
-30,364
-1% -$3.04M 0.26% 102
2015
Q2 		$228M Buy
2,147,833
+26,121
+1% +$2.89M 0.26% 106
2015
Q1 		$242M Buy
2,121,712
+15,934
+0.8% +$1.82M 0.27% 106
2014
Q4 		$232M Sell
2,105,778
-74,541
-3% -$7.86M 0.26% 114
2014
Q3 		$213M Buy
2,180,319
+38,985
+2% +$3.83M 0.23% 121
2014
Q2 		$216M Sell
2,141,334
-138,937
-6% -$13.6M 0.24% 117
2014
Q1 		$209M Buy
2,280,271
+19,797
+0.9% +$1.82M 0.25% 109
2013
Q4 		$205M Sell
2,260,474
-130,316
-5% -$11.3M 0.25% 111
2013
Q3 		$191M Sell
2,390,790
-415,378
-15% -$32.7M 0.25% 108
2013
Q2 		$204M Buy
+2,806,168
New +$210M 0.29% 92

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's ZBH Position: Q1 2019 in Review

OppenheimerFunds increased its Zimmer Biomet (ZBH) stake by 7.9% in Q1 2019, buying an estimated $27.1M and bringing the position to 3,251,023 shares worth $403M. The position accounts for 0.5% of the portfolio, ranked #47.

OppenheimerFunds first reported a position in ZBH in Q2 2013 and has held it in 24 quarters since. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

  • OppenheimerFunds held 3,251,023 shares of Zimmer Biomet worth $403M as of Q1 2019.
  • OppenheimerFunds bought 238,246 Zimmer Biomet shares in Q1 2019, an estimated $27.1M.
  • Zimmer Biomet made up 0.5% of OppenheimerFunds's portfolio in Q1 2019, its #47 holding.
  • OppenheimerFunds first reported a position in Zimmer Biomet in Q2 2013 and has held it in 24 quarters since.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.